Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
AlphaRx signed a long-term contract manufacturing...
Guangzhou Improve Medical Instruments Co. is scheduled to...
AlphaRx, Inc. plans to list its Canadian subsidiary on a...
Lilly is investing “aggressively” in China...
AlphaRx, Inc. announced that its newly formed China...
WuXi PharmaTech (药明康德), continuing the string of...
The CBT 200 Gets Hosed. More details...
AlphaRx (OTCBB: ALRX) has begun applying...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
